Cargando…

Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial

Background: Exercise has considerable effects on physical and psychological health. Anxiolytic effects of climbing exercise have been found in people suffering from depression. However, there are no studies on patients with severe anxiety disorders or post-traumatic stress disorder (PTSD) practicing...

Descripción completa

Detalles Bibliográficos
Autores principales: Bichler, Carina S., Niedermeier, Martin, Hüfner, Katharina, Gálffy, Mátyás, Gostner, Johanna M., Nelles, Philipp, Schöttl, Stefanie E., Sperner-Unterweger, Barbara, Kopp, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517148/
https://www.ncbi.nlm.nih.gov/pubmed/36141895
http://dx.doi.org/10.3390/ijerph191811622
_version_ 1784798867701628928
author Bichler, Carina S.
Niedermeier, Martin
Hüfner, Katharina
Gálffy, Mátyás
Gostner, Johanna M.
Nelles, Philipp
Schöttl, Stefanie E.
Sperner-Unterweger, Barbara
Kopp, Martin
author_facet Bichler, Carina S.
Niedermeier, Martin
Hüfner, Katharina
Gálffy, Mátyás
Gostner, Johanna M.
Nelles, Philipp
Schöttl, Stefanie E.
Sperner-Unterweger, Barbara
Kopp, Martin
author_sort Bichler, Carina S.
collection PubMed
description Background: Exercise has considerable effects on physical and psychological health. Anxiolytic effects of climbing exercise have been found in people suffering from depression. However, there are no studies on patients with severe anxiety disorders or post-traumatic stress disorder (PTSD) practicing climbing as add-on treatment. Additionally, many studies on physical therapy fail to use adequate active control groups. Therefore, this study aimed to investigate the feasibility of a four-week climbing exercise program for patients with anxiety disorders or PTSD in comparison to a standard exercise treatment and a social control group. Methods: Outpatients diagnosed with anxiety disorders or PTSD (F 40, F 41, F 43.1 according to ICD-10) were randomly assigned to (a) climbing exercise (n = 27), (b) Nordic walking exercise (n = 23), or (c) control condition (n = 23) providing the same amount of social contact for eight sessions of 90 minutes each. Psychological parameters (symptom severity, worry symptoms, self-efficacy, quality of life) and biological parameters were assessed at the beginning and at the end of the four-week program. Additionally, follow-up assessments were conducted three and six months after the program ended. Results: Sixty outpatients (75% female) aged 18–65 years with a longstanding history of a mental disorder (>10 years) and classified as treatment-resistant (95%) and with averaging 3.8 psychiatric comorbidities completed the pilot trial. After participation, symptoms of anxiety disorders were significantly reduced (p = 0.003), and health-related characteristics significantly improved (depression symptoms: p < 0.001, worry symptoms: p < 0.001, self-efficacy: p < 0.001, quality of life-physical health: p = 0.002, quality of life-psychological health: p = 0.006) in all groups. The feasibility of conducting climbing exercises for the patient groups could be demonstrated, and a general acceptance in the groups was recorded. No significant time-by-group interactions were found. At the completion of the program, psychological parameters improved, while biological parameters remained the same in all three groups. Conclusions: Participation in the climbing group as well as in Nordic walking and social contact groups demonstrated beneficial results in patients with anxiety disorders and PTSD with severe mental burden. Nevertheless, climbing did not show any additional clinically relevant benefits compared to Nordic walking or social contact. Studies with larger sample sizes and qualitative insights are needed to further evaluate the possible benefits of climbing in this population.
format Online
Article
Text
id pubmed-9517148
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95171482022-09-29 Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial Bichler, Carina S. Niedermeier, Martin Hüfner, Katharina Gálffy, Mátyás Gostner, Johanna M. Nelles, Philipp Schöttl, Stefanie E. Sperner-Unterweger, Barbara Kopp, Martin Int J Environ Res Public Health Article Background: Exercise has considerable effects on physical and psychological health. Anxiolytic effects of climbing exercise have been found in people suffering from depression. However, there are no studies on patients with severe anxiety disorders or post-traumatic stress disorder (PTSD) practicing climbing as add-on treatment. Additionally, many studies on physical therapy fail to use adequate active control groups. Therefore, this study aimed to investigate the feasibility of a four-week climbing exercise program for patients with anxiety disorders or PTSD in comparison to a standard exercise treatment and a social control group. Methods: Outpatients diagnosed with anxiety disorders or PTSD (F 40, F 41, F 43.1 according to ICD-10) were randomly assigned to (a) climbing exercise (n = 27), (b) Nordic walking exercise (n = 23), or (c) control condition (n = 23) providing the same amount of social contact for eight sessions of 90 minutes each. Psychological parameters (symptom severity, worry symptoms, self-efficacy, quality of life) and biological parameters were assessed at the beginning and at the end of the four-week program. Additionally, follow-up assessments were conducted three and six months after the program ended. Results: Sixty outpatients (75% female) aged 18–65 years with a longstanding history of a mental disorder (>10 years) and classified as treatment-resistant (95%) and with averaging 3.8 psychiatric comorbidities completed the pilot trial. After participation, symptoms of anxiety disorders were significantly reduced (p = 0.003), and health-related characteristics significantly improved (depression symptoms: p < 0.001, worry symptoms: p < 0.001, self-efficacy: p < 0.001, quality of life-physical health: p = 0.002, quality of life-psychological health: p = 0.006) in all groups. The feasibility of conducting climbing exercises for the patient groups could be demonstrated, and a general acceptance in the groups was recorded. No significant time-by-group interactions were found. At the completion of the program, psychological parameters improved, while biological parameters remained the same in all three groups. Conclusions: Participation in the climbing group as well as in Nordic walking and social contact groups demonstrated beneficial results in patients with anxiety disorders and PTSD with severe mental burden. Nevertheless, climbing did not show any additional clinically relevant benefits compared to Nordic walking or social contact. Studies with larger sample sizes and qualitative insights are needed to further evaluate the possible benefits of climbing in this population. MDPI 2022-09-15 /pmc/articles/PMC9517148/ /pubmed/36141895 http://dx.doi.org/10.3390/ijerph191811622 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bichler, Carina S.
Niedermeier, Martin
Hüfner, Katharina
Gálffy, Mátyás
Gostner, Johanna M.
Nelles, Philipp
Schöttl, Stefanie E.
Sperner-Unterweger, Barbara
Kopp, Martin
Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial
title Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial
title_full Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial
title_fullStr Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial
title_full_unstemmed Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial
title_short Climbing as an Add-On Treatment Option for Patients with Severe Anxiety Disorders and PTSD: Feasibility Analysis and First Results of a Randomized Controlled Longitudinal Clinical Pilot Trial
title_sort climbing as an add-on treatment option for patients with severe anxiety disorders and ptsd: feasibility analysis and first results of a randomized controlled longitudinal clinical pilot trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517148/
https://www.ncbi.nlm.nih.gov/pubmed/36141895
http://dx.doi.org/10.3390/ijerph191811622
work_keys_str_mv AT bichlercarinas climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT niedermeiermartin climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT hufnerkatharina climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT galffymatyas climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT gostnerjohannam climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT nellesphilipp climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT schottlstefaniee climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT spernerunterwegerbarbara climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial
AT koppmartin climbingasanaddontreatmentoptionforpatientswithsevereanxietydisordersandptsdfeasibilityanalysisandfirstresultsofarandomizedcontrolledlongitudinalclinicalpilottrial